2022 Citation Impact
0.914 - SNIP (Source Normalized Impact per Paper)
0.506 - SJR (SCImago Journal Rank)
2023 Usage
640,615 downloads
196 Altmetric mentions
Volume 15 Supplement 10
Publication of this supplement has been supported by sponsorship. AstraZeneca International has supported in meeting arrangement and sponsored the development of article. The article has undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.
Munich, Germany21 October 2018
The therapeutic landscape of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer (mBC) has evolved considerably with the introduction of newer ta...
2022 Citation Impact
0.914 - SNIP (Source Normalized Impact per Paper)
0.506 - SJR (SCImago Journal Rank)
2023 Usage
640,615 downloads
196 Altmetric mentions